A nyulak járványos enteropathiája okozta veszteségek megelözése bacitracin-És oxitetraciklintartalmú készítménnyel hazai hízónyúlallományokban

Translated title of the contribution: Prevention of losses due to epizootic rabbit enteropathy by product containing bacitracin and oxitetracycline in Hungarian commercial rabbit flocks

Német Zoltán, Biksi Imre, Szenci Ottó, Kis Tamás, Csere István

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Epizootic rabbit enteropathy (ERE), a disease of still unknown aetiology has emerged worldwide in the past decade, as the most important health problem in rabbit industry. Despite its still obscure pathogenesis, ERE can be effectively prevented by strategic oral bacitracin therapy. The authors tested the efficacy of a bacitracin and oxitetracycline combination in the prevention of ERE on 21 commercial Hungarian rabbit farms in the process of licence renewal and claim extension of Trierra A.U.V. medication. Their results clearly showed the benefit of this medication in the prevention of ERE, as it has been reported previously from other countries, as well. Based on historical data, average fattening mortality was about 22% in the untreated groups, which decreased dramatically to about 5% in the treated groups.

Translated title of the contributionPrevention of losses due to epizootic rabbit enteropathy by product containing bacitracin and oxitetracycline in Hungarian commercial rabbit flocks
Original languageHungarian
Pages (from-to)361-366
Number of pages6
JournalMagyar Allatorvosok Lapja
Volume132
Issue number6
Publication statusPublished - Jun 1 2010

ASJC Scopus subject areas

  • veterinary(all)

Fingerprint Dive into the research topics of 'Prevention of losses due to epizootic rabbit enteropathy by product containing bacitracin and oxitetracycline in Hungarian commercial rabbit flocks'. Together they form a unique fingerprint.

  • Cite this